All Posts

Type 1 diabetes is often diagnosed only after a child develops unmistakable symptoms—and sometimes after the child is hospitalized with diabetic ketoacidosis. A large screening study suggests there may be a better way to identify the disease earlier. Researchers in Germany screened more than 220,000 children for early-stage type 1 diabetes during routine pediatric visits. Their findings add to growing evidence that a simple blood test can identify children whose immune system

A new FDA approval may help some children with newly diagnosed type 1 diabetes preserve their remaining natural insulin production for longer. In June 2026, the U.S. Food and Drug Administration granted accelerated approval to Tzield, also known as teplizumab-mzwv, for children ages 8 through 17 who have recently been diagnosed with stage 3 type 1 diabetes. The treatment is intended to delay the decline of the body’s own insulin production. The approval is significant because

Cigna animated square.mp4 Managing diabetes is already a full-time job. Getting the supplies you need should not become another one. As someone living with diabetes, you may know the routine all too well: calling the pharmacy, sitting on hold, learning that your CGM sensors are backordered, discovering that your prescription needs another approval or worrying that you will run out of pump supplies before the next order is ready. Direct Diabetes has an important announcement t

For millions of people living with diabetes, one of the biggest concerns is protecting their eyesight. Diabetic retinal disease often develops silently, causing damage long before blurry vision or other symptoms appear. Now, researchers have developed an artificial intelligence (AI)-powered blood test that could identify early retinal damage before patients even notice a problem. The technology could one day make it easier for doctors to identify high-risk patients and begin

For families managing type 1 diabetes, every meal, snack, birthday party, and school lunch often comes with another insulin injection. That routine may soon become much easier. The U.S. Food and Drug Administration (FDA) has approved Afrezza®, an inhaled mealtime insulin, for children and adolescents ages 6 and older living with type 1 or type 2 diabetes. The approval makes Afrezza the first and only needle-free mealtime insulin available for pediatric patients in the United

New study shows promising functional cure for Type 1 diabetes Watch this story above from WPXI-TV News in Pittsburgh Imagine living with type 1 diabetes for 30 years and suddenly not needing insulin shots or an insulin pump anymore. That's exactly what happened in a new study that has researchers excited. Scientists at the University of Chicago Medicine tested a new treatment that helped every participant who received an islet cell transplant become insulin independent. That

If you've been told to avoid potatoes because of diabetes, new research suggests that advice may need a serious update — because not all potatoes are created equal. A large study published in The BMJ tracked more than 205,000 U.S. health professionals over nearly 40 years and found that eating three servings of French fries per week was linked to a 20% higher risk of developing type 2 diabetes, while baked, boiled, or mashed potatoes showed no significant increase in risk. It

Credit: Jake Belcher for Tufts University Credit: Jake Belcher for Tufts UniversityAt least a dozen U.S. states are rolling out medically tailored meals in pilot projects through Medicaid, the federal–state health insurance program serving 71 million Americans who qualify based on income or disability status. Now, the first large statewide analysis of Medicaid data finds that people with diabetes, heart disease, depression, and other conditions who received these home-deliver

For decades, getting diagnosed with diabetes has meant a trip to the doctor, a blood draw, and a wait for results comparing your blood sugar to a clinical cutoff. If you're above the threshold, you have diabetes. If not, you're sent home — even if your metabolism has been quietly struggling for years. Researchers are now calling that system out for what it is: too slow, too blunt, and missing far too many people. A wave of new tools — combining wearable sensors, advanced biom

Could a new oral therapy help protect new mothers from developing type 2 diabetes after pregnancy? A groundbreaking initiative from Cirius Therapeutics says yes — and the Gates Foundation agrees. Gestational diabetes is one of the most common pregnancy complications in the world — and one of the most underestimated. While it typically resolves after delivery, the long-term health consequences for mothers can be severe. Now, a Michigan-based biotech company has secured a Gates

If you or someone you love is living with prediabetes, new research may offer a ray of hope — and it comes from a source as simple as sunlight. A study recently published in JAMA Network Open has found that high-dose vitamin D supplementation may significantly reduce the risk of developing type 2 diabetes, but with an important catch: it only works for people with certain genetic variations. Here's what you need to know. What the New Research Found More than two in five U.S.

The library at The University of California San Diego. The library at The University of California San Diego.A breakthrough study from UC San Diego has developed a machine learning model that identifies Type 1 diabetes risk in a broader population — including people who would have been missed by older genetic tests. What Just Changed in Type 1 Diabetes Genetic Screening For decades, genetic testing for Type 1 diabetes (T1D) has had a significant blind spot: it worked best for

A landmark clinical trial shows oral semaglutide significantly lowers blood sugar in children aged 10–17, paving the way for the first-ever oral GLP-1 treatment approved for young patients with type 2 diabetes. A Growing Crisis in Young People Type 2 diabetes is no longer just an adult disease. Once called "adult-onset diabetes," the condition is increasingly diagnosed in children and adolescents — and the numbers are alarming. According to Novo Nordisk, approximately 14.6 mi

Comedy legend Damon Wayans Sr. is speaking out about a serious diabetes complication that disproportionately affects communities of color — and he says staying silent is simply not an option. When In Living Color and My Wife and Kids star Damon Wayans Sr. was diagnosed with Type 2 diabetes in 2008 at the age of 47, it was no laughing matter — even for one of America's most beloved comedians. He was rushed to the hospital on the verge of a diabetic coma, with blood sugar level

If you’re placing continuous glucose monitor (CGM) orders, you’re balancing speed with constant follow-up—prior auth issues, missing documentation, patient confusion, and pharmacy callbacks. While ordering through your EHR may feel faster in the moment, it often creates more work after the order is sent. There’s a more efficient workflow that reduces those downstream headaches—and it’s completely free to use: ParachuteHealth.com. What Is Parachute Health—and What Does It Cost

A new study from the University of New Mexico is shedding light on a powerful, often overlooked tool in diabetes management: personalized strength training. Researchers at UNM Health Sciences Center are exploring how tailored exercise programs—especially resistance training—can significantly improve outcomes for people living with diabetes. This emerging research suggests that not all exercise is created equal. Instead, customizing workouts to an individual’s body, metabolism

For children living with diabetes, summer camp can be more than just fun—it can be life-changing. American Diabetes Association (ADA) Camps are designed specifically for kids with type 1 and type 2 diabetes, offering a safe, supportive environment where they can enjoy classic camp activities while learning how to manage their condition with confidence. These camps, hosted across the United States, combine medical expertise with unforgettable childhood experiences. From swimmi

Type 1 diabetes (T1D) research is entering a pivotal moment. According to a recent report from the University of California, more than 2 million Americans could benefit from the next generation of treatments currently being developed. From immune-targeting drugs to lab-grown cell therapies, scientists are moving closer to changing how T1D is treated—and potentially preventing it altogether. Here’s where research stands today, who is leading it, and what the future may look li

Artificial intelligence is transforming how we understand and treat chronic diseases—and one of the most promising breakthroughs is happening deep inside the human gut. New research from Cedars-Sinai shows how AI-powered mapping of the gut microbiome could redefine how type 2 diabetes is diagnosed, prevented, and treated. By uncovering patterns in gut bacteria, scientists are getting closer to truly personalized diabetes care. Why the Gut Matters in Type 2 Diabetes The gut...

GLP-1 medications like Ozempic and Wegovy have quickly become some of the most talked-about treatments for type 2 diabetes and weight loss. But new research from Stanford Medicine reveals a critical reality: these medications don’t work for everyone. In fact, about 1 in 10 patients see little to no benefit—and scientists are now beginning to understand why. GLP-1 Medications: Highly Effective—But Not Universal GLP-1 (glucagon-like peptide-1) receptor agonists are designed to: